Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results

BMC Women's Health

Volumn 6, Issue , 2006, Pages

  Cetina, Lucely ^a   Rivera, Lesbia ^a   Hinojosa, José ^a   Poitevin, Adela ^a   Uribe, Jesús ^a   López Graniel, Carlos ^a   Cantú, David ^a   Candelaria, Myrna ^a   de la Garza, Jaime ^a   Dueñas González, Alfonso ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; ONDANSETRON;

ABSENCE OF SIDE EFFECTS; ADVANCED CANCER; ANOREXIA; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DEHYDRATION; DERMATITIS; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG TOLERABILITY; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; KIDNEY FAILURE; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PROCTITIS; RADIATION DOSE; RETROSPECTIVE STUDY; SEPSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CANCER;

EID: 33644663022     PISSN: 14726874     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-6-3     Document Type: Article

References (23)

1. Dueñas-González A, Cetina L, Mariscal I, de la Garza J: Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003, 29:389-399.
2. Mohar A, Frías-Mendivil M: Epidemiology of cervical cancer. Cancer Invest 2000, 18:584-590.
3. Peters WA 3rd, Liu PY, Barrett R, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000, 18:1606-1613.
4. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gerhenson DM, Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340:1137-1143.
5. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D: A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: a randomized trial of the Gynecology Oncology Group. N Engl J Med 1999, 340:1154-1161.
6. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalacos S: Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study. N Engl J Med 1999, 340:1144-1153.
7. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY: A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999, 17:1339-1348.
8. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ: Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001, 358:781-786.
9. Black AK, Allen LH, Pelto GH, de Mata MP, Chávez A: Iron, vitamin B-12 and folate status in Mexico: associated factors in men and women and during pregnancy and lactation. J Nutr 1994, 124:1179-1188.
10. Kiefe C, Funkhouser E, Fouad M, May D: Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 1998, 13:357-365.
11. Massad LS, Calvello C, Gilkey SH, Abu-Rustum NR: Assessing disease extent in women with bulky or clinically evident metastatic cervical cancer: yield of pretreatment studies. Gynecol Oncol 2000, 76:383-387.
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
13. Sismondi P, Sinistrero G, Zola P, Volpe T, Ferraris R, Castelli GL, Giai M: Complications of uterine cervix carcinoma treatments: the problem of a uniform classification. Radiother Oncol 1989, 14:9-17.
14. Maduro JH, Pras E, Willemse PH, de Vries EG: Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 2003, 29:471-488.
15. Tan LT, Russell S, Burgess L: Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2004, 16:255-260.
16. Abu-Rustum NR, Lee S, Correa A, Massad LS: Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol 2001, 81:88-91.
17. Serkies K, Jassem J: Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Int J Radiat Oncol Biol Phys 2004, 60:814-821.
18. Cubillo A, Cornide M, López JL, Molina R, Feliu J, Espinosa E, Zamora P, de Castro J, Ordoñez A, González Barón M: Renal tolerance to cisplatin in patients 70 years and older. Am J Clin Oncol 2001, 24:192-197.
19. Stewart DJ, Dulberg CS, Mikhael NZ, Redmond MD, Montpetit VA, Goel R: Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods. Cancer Chemother Pharmacol 1997, 40:293-308.
20. Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Vaccaro V, Ravera M, Tomolillo C, Deferrari G, Pontremoli R: Creatinine clearance and signs of end-organ damage in primary hypertension. J Hum Hypertens 2004, 18:511-516.
21. Caramori M, Fioretto P, Mauer M: The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000, 49:1399-1408.
22. Dueñas-González A, Cetina L, Sánchez B, Gómez E, Rivera L, Hinojosa J, López-Graniel C, González-Enciso A, de la Garza J: A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:1361-1365.
23. Cetina L, Rivera L, Candelaria M, de la Garza J, Dueñas-González A: Chemoradiation with gemcitabine for cervical cancer in patients with renal failure. Anticancer Drugs 2004, 15:761-766.